BG-C477
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for BG-C477, covering 2026-04-23 to 2026-04-23. Get the full timeline:
Most recent: Clinical Trial Update: A Study of BG-C477 in Participants With Advanced Solid Tumors [Phase 1]